Insulin initiation in elderly patients with type 2 diabetes in France: A subpopulation of the LIGHT study

Current Medical Research and Opinion

Volumn 28, Issue 4, 2012, Pages 503-511

  Kerlan, Véronique ^a   Vergés, Bruno ^b   Tawil, Camille ^c   Lahrichi, Nora ^d   Doucet, Jean ^e  

^a BREST UNIVERSITY HOSPITAL   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c Novo Nordisk ^*  (France)

^d NOVO NORDISK A S   (Denmark)

^e ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Basal insulin; Elderly; Initiation; Type 2 diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT CHANGE;

EID: 84859699103     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.664549     Document Type: Article

References (40)

1. Bonaldi C, Romon I, Fagot-Campagna A. Impacts du vieillissement de la population et de l'obé sité sur l'é volution de la pré valence du diabè te traité : situation de la France mé tropolitaine à l'horizon 2016. Bulletin Epidemiologique Hebdomadaire 2006;10:69-76
2. Fagot-Campagna A, Bourdel-Marchasson I, Simon D. Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab 2005;31:5S35-5S52 (Pubitemid 43106442)
3. Fagot-Campagna A, Fosse S, Roudier C, et al, pour le Comité scientifique d'Entred. Characteristics, vascular risk and complications in people with diabetes, in metropolitan France: major improvements between ENTRED 2001 and ENTRED 2007 studies. Bulletin Epidemiologique Hebdomadaire 2009;42-43:455-60
4. Bertoni AG, Krop JS, Anderson GF, et al. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 2002;25:471-5 (Pubitemid 41103338)
5. Samos LF, Roos BA. Diabetes mellitus in older persons. Med Clin North Am 1998;82:791-803 (Pubitemid 28350783)
6. Meneilly GS, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 1994;43:403-10 (Pubitemid 24064247)
7. Lassmann-Vague V. Hypoglycaemia in elderly diabetic patients. Diabetes Metab 2005;31:5S53-5S57 (Pubitemid 43106443)
8. Lindström T, Jorfeldt L, Tegler L, et al. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet Med 1992;9:536-41
9. Desouza C, Salazar H, Cheong B, et al. Association of hypoglycaemia and cardiac ischaemia: a study based on continuous monitoring. Diabetes Care 2003;26:1485-9 (Pubitemid 36929183)
10. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72
11. Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39
12. ACCORD Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59 (Pubitemid 351831356)
13. Lachin JM. Point: intensive glycemic control and mortality in ACCORD-a chance finding? Diabetes Care 2010;33:2719-21
14. Riddle, MC. Counterpoint: intensive glucose control and mortality in ACCORD-still looking for clues. Diabetes Care 2010;33:2722-4
15. Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Health, Aging, and Body Composition Study. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008;31:391-6
16. Ober SK, Watts S, Lawrence RH. Insulin use in elderly diabetic patients. Clin Interv Aging 2006;1:107-13
17. Constans T. Plasma glucose goals and therapeutic management in elderly diabetic patients. Diabetes Metab 2005;31:5S58-5S61 (Pubitemid 43106444)
18. Pornet C, Bourdel-Marchasson I, Lecomte P, et al., for the ENTRED Scientific Committee. Trends in the quality of care for elderly people with type 2 diabetes: the need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys). Diabetes Metab 2011;37:152-61
19. Blicklé JF, Attali JR, Barrou Z, et al. Rapport des experts de l'ALFEDIAM. Le diabè te du sujet â gé . Diabetes Metab 1999;25:84-93
20. Sweileh WM. Contraindications to metformin therapy among patients with type 2 diabetes mellitus. Pharm World Sci 2007;29:587-92. (Pubitemid 47594163)
21. Erratum in Pharm World Sci 2007;29:573
22. Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
23. Doucet J. Use of antidiabetic drugs in elderly patients. Diabetes Metab 2005;31:5S98-5S104 (Pubitemid 43106452)
24. Heinemann L, Linkeschova R, Rave K, et al. Time-action profile of the longacting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23:644-9 (Pubitemid 30321545)
25. Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-8
26. Hovath K, Jeitler K, Berghold A, et al. Long-acting analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007;CD005613
27. Bazzano LA, Lee LJ, Reynolds K, et al. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabet Metab 2008; 25:924-32
28. Philis-Tsimikas A, Charpentier G, Clauson P, et al. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006;28:1569-81 (Pubitemid 44856694)
29. Garber AJ, Clauson P, Pedersen CB, et al. Lower risk of hypoglycaemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials. J Am Geriatr Soc 2007;55:1735-40 (Pubitemid 350043780)
30. Brez S, Rowan M, Malcolm J, et al. Transition from specialist to primary diabetes care: a qualitative study of perspectives of primary care physicians. BMC Fam Pract 2009;10:39
31. Vergè s B, Brun JM, Tawil C, et al. Strategies for insulin initiation: insights from the French LIGHT observational study. Diabetes Metab Res Rev. 2012 Jan; 28(1):97-105
32. ALFEDIAM. Guide pour la prise en charge du diabé tique â gé. 1è re é dition. Medecine des Maladies Metaboliques 2008;2:1-120
33. Doucet B, Bauduceau J-P, Le Floch JP, et al. É tude GERODIAB: descriptif de 985 patients diabé tiques de type 2 â gé s de plus de 70 ans. Diabetes Metab 2011;37(Suppl 1):A59
34. Yki-Jä rvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001;24:758-67 (Pubitemid 32888861)
35. Yki-Jä rvinen H, Ryysy L, Kaupilla M, et al. Effect of obesity on the response to insulin therapy in non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:4037-43 (Pubitemid 27525508)
36. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002;26(Suppl 3):S18-S24 (Pubitemid 35034478)
37. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes-causes, effects and coping mechanisms. Diabetes Obes Metab 2007; 9:799-812 (Pubitemid 47555203)
38. Donnelly LA, Morris AD, Evans JM; DARTS/MEMO collaboration. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007;100:345-50 (Pubitemid 47073810)
39. Brownie S. Why are elderly individuals at risk of nutritional deficiency? Int J Nurs Pract 2006;12:110-18
40. Ligthelm RJ, Borz?̀ V, Gumprecht J, et al. Importance of observational studies in clinical practice. Clin Ther 2007;29:1284-92 (Pubitemid 351181208)